This content is machine translated Diabetic nephropathy Dapagliflozin and pioglitazone are not inferior as lone fighters The treatment of diabetic nephropathy (DN) has made significant progress in the past. Nevertheless, the number of diabetic patients who ultimately develop end-stage renal disease remains high. A combination of…
View Post 4 min This content is machine translated Renal effects of empagliflozin Combination with semaglutide does not reduce albuminuria more than Empa mono SGLT2 inhibitors and GLP1 receptor agonists (GLP1-RA) are antidiabetic drugs with the potential to preserve kidney function. Their different mechanisms of action suggest that combination therapy could have additive or…
View Post 5 min This content is machine translated Medidays Zurich 2017 Diabetes mellitus type 2 – Targeted through the drug jungle The number of people suffering from diabetes continues to rise. According to an estimate by the International Diabetes Federation, approximately 592 million people will be affected in 2035. This disease,…
View Post 9 min This content is machine translated New antidiabetic agents Combination therapies enable very potent HbA1c reduction Lifestyle modification (exercise, diet) and metformin remain the cornerstones in the treatment of diabetes mellitus type 2. Before initiating antidiabetic therapy, it is recommended to set an individual HbA1c target. Advantages…
View Post 8 min This content is machine translated Insulin in type 2 diabetes When and in which combination? The current therapy guidelines for diabetes mellitus type 2 provide for the use of insulin as initial therapy as well as a later therapy option in monotherapy or in combination with…
View Post 4 min This content is machine translated Diabetes during pregnancy Which preparation helps? Almost 9% of pregnant women develop gestational diabetes. Recently, new diagnostic criteria have become available. Both insulin and oral antidiabetic agents are available for therapy. At the DIP symposium (The7th…
